Scientists hunt for blood 'Fingerprint' to predict Cancer's return
NCT ID NCT00086567
Summary
This study aimed to develop a new blood test to better predict if ovarian, peritoneal, or fallopian tube cancer will come back after successful treatment. Researchers collected blood samples from 119 women whose cancer was in remission to look for specific patterns of proteins that might signal a high risk of relapse. The goal was to create a more accurate tool than the current standard test (CA-125) to help doctors monitor patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048-1804, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Evanston Northwestern University Hospital
Evanston, Illinois, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Massachusetts General Hospital, Dana Farber
Boston, Massachusetts, 02114, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
New York University School of Medicine
New York, New York, 10016, United States
-
Pacific Ovarian Cancer Research Consortium at FHCRC
Seattle, Washington, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Washington/Fred Hutchinson Cancer Research Center
Seattle, Washington, 28104, United States
Conditions
Explore the condition pages connected to this study.